U.S. market Closed. Opens in 11 hours 18 minutes

DBD | Diebold Nixdorf, Incorporated Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for DBD we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is stunning wealthy, Growth is good and Health is weak.

Valuation (71%)

Company Industry
P/E Ratio (TTM) 0.75 40.40
PEG Ratio (TTM) 0.00 1.00
P/S Ratio (TTM) 0.42 10.65
P/B Ratio (TTM) 1.62 12.24
P/FCF Ratio (TTM) 701.84 45.17
Price to 5YR AVG Earnings Ratio 10.62 71.95
Price to 5YR AVG FCF Ratio -12.84 66.39

Profitability (85%)

Company Industry
ROA (TTM) 55.78% -4.60%
ROE (TTM) 212.05% 5.31%
Net Profit Margin (TTM) 56.28% -2.18%
ROIC 5YR AVG 6.18% 6.06%

Growth (65%)

4QTR AVG 3YR AVG 5YR AVG
EPS 179.17% 30.95% 10.50%
Revenue 0.88% -3.80% -2.83%
Net Income 90.54% 30.87% -43.85%
Cash Flow 78.97% 166.09% 23.48%

Health (46%)

Company Industry
Current Ratio (TTM) 1.42 1.88
Quick Ratio (TTM) 0.95 2.17
D/E Ratio (TTM) 1.10 0.43
Interest Coverage (TTM) 1.26 0.69
Piotroski F-Score 6 6
Altman Z-Score 3.61 8.67
LTL to 5YR AVG FCF -9.96 3.68
Shares Outstanding Growth 5YR AVG -9.89% 44.37%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙